رجوع
نطاق اليوم
KWD 97.79
KWD 100.72
نطاق 52 أسبوعًا
KWD 89.75
KWD 124.44
حجم التداول
202,812
متوسط 50 يوم / 200 يوم
KWD 106.92
/
KWD 111.86
الإغلاق السابق
KWD 99.78
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 19.3 | 0.3 |
| P/B | 1.7 | 2.9 |
| ROE % | 9.3 | 3.7 |
| Net Margin % | 6.7 | 3.8 |
| Rev Growth 5Y % | 13.3 | 10.0 |
| D/E | 0.2 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 128.670
+29.6%
Low: KWD 112.000
High: KWD 139.000
مكرر الربحية المستقبلي
14.4
ربحية السهم المستقبلية
KWD 6.909
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
1.5 B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2028 |
KWD 8.084
KWD 7.005 – KWD 8.933
|
1.7 B | 3 |
| FY2027 |
KWD 7.475
KWD 7.290 – KWD 7.580
|
1.6 B | 7 |
| FY2026 |
KWD 6.909
KWD 6.828 – KWD 6.949
|
1.5 B | 8 |
النقاط الرئيسية
Revenue grew 13.26% annually over 5 years — strong growth
Earnings grew 30.32% over the past year
Debt/Equity of 0.19 — conservative balance sheet
Negative free cash flow of 0.0
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 9.95%
Capital efficient — spends only 7.84% of revenue on capex
النمو
Revenue Growth (5Y)
13.26%
Revenue (1Y)23.21%
Earnings (1Y)30.32%
FCF Growth (3Y)N/A
الجودة
Return on Equity
9.33%
ROIC8.03%
Net Margin6.74%
Op. Margin9.74%
الأمان
Debt / Equity
0.19
Current Ratio1.80
Interest Coverage14.46
التقييم
P/E Ratio
19.30
P/B Ratio1.71
EV/EBITDA14.27
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 23.21% | Revenue Growth (3Y) | 15.92% |
| Earnings Growth (1Y) | 30.32% | Earnings Growth (3Y) | 23.86% |
| Revenue Growth (5Y) | 13.26% | Earnings Growth (5Y) | 20.74% |
| Profitability | |||
| Revenue (TTM) | 1.42B | Net Income (TTM) | 95.91M |
| ROE | 9.33% | ROA | 6.67% |
| Gross Margin | 32.47% | Operating Margin | 9.74% |
| Net Margin | 6.74% | Free Cash Flow (TTM) | 0.0 |
| ROIC | 8.03% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.19 | Current Ratio | 1.80 |
| Interest Coverage | 14.46 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 19.30 | P/B Ratio | 1.71 |
| P/S Ratio | 1.30 | PEG Ratio | 1.04 |
| EV/EBITDA | 14.27 | Dividend Yield | 0.00% |
| Market Cap | 1.85B | Enterprise Value | 1.98B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.42B | 1.15B | 1.06B | 951.12M | 864.50M |
| Net Income | 95.91M | 73.60M | 62.52M | 46.03M | 45.13M |
| EPS (Diluted) | 5.21 | 4.23 | 3.83 | 2.84 | 2.81 |
| Gross Profit | 461.87M | 375.02M | 339.88M | 299.74M | 269.85M |
| Operating Income | 138.62M | 102.69M | 90.96M | 68.74M | 65.94M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.44B | 1.41B | 1.02B | 937.99M | 947.59M |
| Total Liabilities | 352.01M | 442.14M | 317.73M | 304.45M | 373.24M |
| Shareholders' Equity | 1.09B | 970.49M | 706.69M | 633.54M | 574.34M |
| Total Debt | 208.62M | 273.13M | 175.18M | 178.05M | 263.55M |
| Cash & Equivalents | 81.62M | 98.91M | 64.79M | 79.96M | 168.90M |
| Current Assets | 269.49M | 260.38M | 200.00M | 222.81M | 324.34M |
| Current Liabilities | 149.49M | 155.87M | 145.12M | 131.15M | 117.69M |